Entry |
|
Name |
Doxribtimine (USAN/INN) |
Formula |
C10H14N2O5
|
Exact mass |
242.0903
|
Mol weight |
242.2286
|
Structure |
|
Remark |
|
Efficacy |
Methabolic disease therapeutic agent |
Comment |
Treatment of thymidine kinase 2 deficiency
|
Target |
|
Pathway |
hsa00983 | Drug metabolism - other enzymes |
|
Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Phosphotransferase
TK2
D12466 Doxribtimine (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 17
1 C1y C 18.4887 -16.5203
2 O2x O 17.3639 -15.6768
3 C1x C 18.0669 -17.8560
4 C1y C 16.2391 -16.5203
5 C1y C 16.6609 -17.8560
6 C1b C 14.9035 -16.0985
7 O1a O 16.2391 -19.1917
8 O1a O 13.8490 -17.0124
9 N4y N 19.8243 -16.2391
10 C8y C 21.0194 -16.9421
11 C8x C 19.8243 -14.8332
12 N4x N 22.2145 -16.2391
13 O5x O 21.0191 -18.3481
14 C8y C 21.0194 -14.1302
15 C8y C 22.2145 -14.8332
16 C1a C 21.0194 -12.7242
17 O5x O 23.4798 -14.1302
BOND 18
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 4 6 1 #Up
6 5 7 1 #Down
7 6 8 1
8 4 5 1
9 9 10 1
10 9 11 1
11 10 12 1
12 10 13 2
13 11 14 2
14 12 15 1
15 14 16 1
16 15 17 2
17 14 15 1
18 1 9 1 #Up
|